Dr Ball on Data From from the IMerge Trial in Low– to Intermediate-Risk MDSBySomedeb Ball, MBBSMay 16th 2024Somedeb Ball, MBBS, discusses data from the phase 3 IMerge trial of imetelstat vs placebo in low– to intermediate-risk myelodysplastic syndromes.
Dr Ball on the Use of Luspatercept in MDS With AnemiaBySomedeb Ball, MBBSApril 12th 2024Somedeb Ball, MBBS, discusses the benefits of luspatercept for patients with anemia due to a myelodysplastic syndrome.